Across 29 randomised trials (7,534 adults with cardiometabolic risk factors), digital commitment devices, tools that apply behavioural economics such as financial stakes or public pledges to lock in intentions, raised daily steps by about 665 (95% CI 463 to 867; I2=0%) and cut body weight by 1.9 kg (95% CI -2.59 to -1.21; I2=70%) versus controls. They also improved self-reported emotional and uncontrolled eating, body fat percentage, diet adherence and medication adherence.
The step effect is consistent across trials, but modest: roughly seven minutes of walking. Observational dose-response work suggests cardiovascular benefit accrues steadily with each additional 500 to 1,000 daily steps, so the gain is not trivial at population scale, yet it will not transform an individual's risk. The 1.9 kg weight loss is real but small beside GLP-1 drugs or intensive lifestyle programmes, and the high heterogeneity (I2=70%) signals that results depend heavily on how the commitment is designed, how large the incentive is and who is enrolled. The most important caveat is durability. Incentive-based interventions often lose their effect once the incentive ends, and the authors themselves call for follow-up beyond 12 months, which means we still lack evidence on blood pressure, lipids, glucose or events. Many outcomes were also self-reported. Editorially, this is a useful confirmation that behavioural-economics nudges work as adjuncts to lifestyle care, not a standalone fix. For adults trying to move more, a commitment contract is a low-cost tool worth trying alongside, not instead of, established approaches.